J2H Biotech is a South Korean bio-corporation established in 2014, specializing in the development of innovative new drugs and manufacturing high-quality drug substances and products
J2H Biotech is a South Korean bio-corporation established in 2014, specializing in the development of innovative new drugs and manufacturing high-quality drug substances and products. The company operates GMP-certified facilities in Ansan and Asan, focusing on manufacturing for domestic and global partners. It is involved in the development of small molecule therapeutics for rare and incurable diseases, utilizing its proprietary platform technology, OPTIFLEX®, in areas such as immunology, anti-f